RxSight, Inc. RXST Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 76.6%+5.9pp | 70.7%+10.4pp | 60.4%+16.8pp | 43.5%+23.5pp | |
| Operating margin | -35.8%-9.5pp | -26.3%+29.9pp | -56.2%+73.0pp | -129.2%+104pp | |
| Net margin | -29%-9.3pp | -19.6%+34.9pp | -54.6%+81.7pp | -136.2%+79.3pp | |
| Returns | |||||
| Return on equity | -14%-1.6pp | -12.4%+26.4pp | -38.8%+19.7pp | -58.5%— | |
| Return on invested capital | -17.7%-0.6pp | -17.1%+19.1pp | -36.2%+8.7pp | -44.9%— | |
| Efficiency | |||||
| Asset turnover | 0.4×-0.1× | 0.6×0.0× | 0.5×+0.2× | 0.3×+0.1× | |
| Liquidity | |||||
| Current ratio | 10.9×-0.4× | 11.4×+3.3× | 8.1×+0.3× | 7.8×-8.1× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×-0.5× | 0.5×+0.2× | |
| Per Share | |||||
| Book value per share | $6.75-6.7% | $7.24+55.5% | $4.65+43.2% | $3.25-68.0% | |
| Valuation | |||||
| Market capitalization | $232.23M-56.8% | $1.39B-4.4% | $1.45B+309% | $354.64M+14.9% | |
| Price / sales | 1.8×-1.8× | 9.9×-6.4× | 16.3×+9.0× | 7.2×-6.4× | |
| Price / book | 0.9×-1.1× | 4.9×-4.1× | 9×+5.1× | 3.9×+1.7× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are RxSight, Inc.'s profit margins?
- RxSight, Inc. (RXST) runs a 77.0% gross margin and a -43.4% operating margin, with a -36.6% net margin.
- Where do RxSight, Inc.'s ratios come from?
- Every ratio is computed from RxSight, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
